Rhonda Fleming v. United States of America, et al.

District Court, N.D. California·Decided March 20, 2026·No. 3:22-cv-05082·Unknown

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA

RHONDA FLEMING, Case No. 22-cv-05082-RFL

Plaintiff, ORDER GRANTING USA’S MOTION v. TO DISMISS AND DENYING WARDEN JUSINO’S MOTION TO UNITED STATES OF AMERICA, et al., DISMISS Defendants. Re: Dkt. Nos. 162, 163

Plaintiff Rhonda Fleming brings suit against Defendants United States of America, William Lothrop (in his official capacity as Acting Director of the Federal Bureau of Prisons (“BOP”)), and Thahesha Jusino, former warden of Federal Correctional Institution, Dublin (“FCI Dublin”). In her operative complaint, Fleming alleges that while she was incarcerated at FCI Dublin, she was subjected to toxic environmental conditions and denied access to necessary medical treatment for her worsening health. (Dkt. No. 133-2 (“TAC”).) Fleming asserts claims under the Federal Tort Claims Act (“FTCA”) for negligence and intentional infliction of emotional distress and an Eighth Amendment claim for injunctive relief against the United States and Lothrop, and an Eighth Amendment Bivens claim for damages against Jusino. (TAC ¶¶ 71– 116.) Defendants move to dismiss the complaint for failure to state a claim under Federal Rule of Civil Procedure 12(b)(6). (Dkt. No. 162 (Jusino); Dkt. No. 163 (United States and Lothrop).) For the reasons that follow, the United States and Lothrop’s motion is GRANTED, and those claims are dismissed without prejudice to being refiled after presenting them to the Bureau of Prisons for its evaluation. Jusino’s motion is DENIED. I. BACKGROUND The facts detailed below are based on the allegations contained in the operative complaint, the truth of which the Court accepts for purposes of resolving the motions to dismiss. See Boquist v. Courtney, 32 F.4th 764, 772 (9th Cir. 2022). A. Conditions at FCI Dublin FCI Dublin was a federal low-security women’s prison in Dublin, California. (TAC ¶ 11.) Although poor living conditions are alleged to have been “serious, systemic problems . . . at FCI Dublin . . . for decades,” whistleblowers and media reports revealing the egregiousness of the living conditions have caused the prison to come under “intense public scrutiny” in recent years. (Id. at ¶¶ 14–15.) Prisoners at FCI Dublin were exposed to mold, asbestos, and walkways covered in wild geese excrement, all of which can cause severe negative health effects including mesothelioma, upper respiratory tract symptoms, and histoplasmosis. (Id. at ¶¶ 16–17.) After officials of the prison workers’ union filed whistleblower complaints in 2022, the U.S. Office of Special Counsel determined that FCI Dublin had violated Occupational Safety and Health Administration standards by exposing prison staff and inmates to asbestos. (Id. at ¶ 18.) Despite all this, however, FCI Dublin “failed to remediate the toxic environmental conditions at the prison.” (Id.) Indeed, in March 2024, a Special Master was appointed to supervise FCI Dublin following a finding by another judge in this District that BOP had “proceeded sluggishly” in ameliorating the environmental conditions in FCI Dublin. (Cal. Coalition for Women Prisoners v. United States, No 23-cv-04155-YGR, Dkt. No. 222 at 1.)1 On April 15, 2024, BOP officials announced that they would close FCI Dublin. (TAC ¶ 21.) Individuals then incarcerated at FCI Dublin were transferred to “various other federal prisons throughout the country.” (Id.) B. Fleming’s Incarceration at FCI Dublin Fleming had originally been transferred from FCI Tallahassee to FCI Dublin on June 22, 2022, allegedly in retaliation for her asking for a prison grievance form. (Id. at ¶¶ 23, 45.) Upon

1 All references to page numbers in documents on the docket refer to ECF pagination. her arrival at FCI Dublin, “her health began to rapidly deteriorate due to the prison’s hazardous environmental conditions,” which she was exposed to “every day of [her] incarceration at FCI Dublin.” (Id. at ¶¶ 24–25.) Bird Feces. Fleming was “without an escape from [bird] feces wherever she went.” (Id. at ¶ 25.) Walkways outside of the prison contained piles of bird feces, and Fleming was forced to walk through those walkways to eat meals at the Food Services building. (Id.) Feces from outside would ultimately get tracked into the building and throughout FCI Dublin’s Housing Unit. (Id.) Mold. “FCI Dublin’s dilapidated infrastructure” caused flooding and perpetual dampness within the prison, which resulted in “the growth of visible, black mold.” (Id. at ¶ 26.) Fleming saw black mold in FCI Dublin’s showers and on its ceiling tiles, floor tiles, and walls. (Id.) Mold was also present in one of Fleming’s cells in FCI Dublin. (Id. at ¶ 27.) The cell had a hole under the sink that was approximately five to six inches wide, exposing Fleming and her cellmate to “visible yellow wall insulation, torn drywall, rotting wood, and visible mold in the area where the water pipes connected to the sink.” (Id.) Fleming alleges that her cellmate “experienced issues clearing her throat, a runny nose, and mild headaches” since moving into the cell, and that her cellmate “believed it to be related to the hole in the wall.” (Id.) Asbestos. FCI Dublin also had asbestos throughout its facilities. (Id. at ¶ 28.) Fleming saw friable asbestos in her cell, in floor and ceiling tiles throughout the prison, and in the pipe insulation. (Id.) Fleming alleges that FCI Dublin staff had “the floor tiles buffed” despite there being asbestos in the tiles, which released asbestos in the air. (Id.) Contaminated Water. On occasion, pipes would break in FCI Dublin, and sewage would mix with the prison’s drinking and bathing water. (Id. at ¶ 29.) When this occurred, Fleming was forced to drink and shower in contaminated water. (Id.) She would experience symptoms “such as an upset stomach, diarrhea, headaches, and skin rashes.” (Id.) Fleming alleges that this occurred approximately ten times during her incarceration at FCI Dublin. (Id.) Lack of Heating. A visit to FCI Dublin by another judge in the District revealed that the prison lacked adequate heating. (Id. at ¶ 30.) Accordingly, the court ordered FCI Dublin to provide each inmate with two blankets due to the lack of heat in certain parts of the prison. (Id.) Fleming alleges that her cell was “in the 40-degree Fahrenheit range” and that conditions were “significantly worse” in the Special Housing Unit (“SHU”). (Id.) According to Fleming, FCI Dublin staff failed to remediate the “toxic environmental conditions at the prison,” and her daily exposure to these conditions, in turn, negatively impacted her health. (Id. at ¶¶ 18, 31.) Though Fleming acknowledges that she had “experienced some breathing difficulties” during her prior incarceration at FCI Tallahassee, “these difficulties quickly escalated following her arrival at FCI Dublin.” (Id. at ¶ 31.) During her incarceration at FCI Dublin, Fleming experienced such symptoms as chronic sinusitis, coughing spasms, headaches, shortness of breath, extreme fatigue, eye irritation, memory problems, and stomach and muscle pain. (Id.) She was diagnosed with asthma and eventually put on medication designed to treat chronic obstructive pulmonary disease. (Id. at ¶ 32.) At one point, “she required a wheelchair because she could no longer walk.” (Id. at ¶ 30.) Despite being transferred out of FCI Dublin on April 19, 2024 (id. at ¶ 23), Fleming continues to experience her symptoms (id. at ¶ 33). She is often unable to “sleep for more than a few hours at a time” due to nighttime coughing fits. (Id.) Despite previously being an avid runner who ran five to six miles, six days a week, Fleming is now unable to run, has gained “significant weight,” and is experiencing hair loss.

Free access — add to your briefcase to read the full text and ask questions with AI

Rhonda Fleming v. United States of America, et al., (N.D. Cal. 2026).

Rhonda Fleming v. United States of America, et al. (Rhonda Fleming v. United States of America, et al.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Davis v. Passman
442 U.S. 228 (Supreme Court, 1979)
Carlson v. Green
446 U.S. 14 (Supreme Court, 1980)
Harlow v. Fitzgerald
457 U.S. 800 (Supreme Court, 1982)
McNeil v. United States
508 U.S. 106 (Supreme Court, 1993)
Department of the Army v. Blue Fox, Inc.
525 U.S. 255 (Supreme Court, 1999)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
John C. McGuckin v. Dr. Smith John C. Medlen, Dr.
974 F.2d 1050 (Ninth Circuit, 1992)
Clarissa Brady,plaintiff-Appellant v. United States
211 F.3d 499 (Ninth Circuit, 2000)
Brown v. Croak
312 F.3d 109 (Third Circuit, 2002)
Harris v. County of Orange
682 F.3d 1126 (Ninth Circuit, 2012)
Cion Peralta v. T. Dillard
744 F.3d 1076 (Ninth Circuit, 2014)
Juan Albino v. Lee Baca
747 F.3d 1162 (Ninth Circuit, 2014)
Dennis Walker v. Beard
789 F.3d 1125 (Ninth Circuit, 2015)
Ziglar v. Abbasi
582 U.S. 120 (Supreme Court, 2017)
Karim Khoja v. Orexigen Therapeutics, Inc.
899 F.3d 988 (Ninth Circuit, 2018)